by Lawrence Mouawad | Jan 15, 2020 | Uncategorised
Our clinical trials registry currently lists 54 studies: 32 CML studies actively recruiting patients, including 2 paediatric trials 7 treatment-free remission trials 20 studies that are no longer recruiting Check here CML Trials Registry We are pleased...
by Lawrence Mouawad | Dec 5, 2019 | Uncategorised
Just a few days left until the 61st ASH Annual Meeting and Exposition opens its doors on 7th until 10th December in Orlando, USA. We are hoping to see many CML Advocates at #ASH19! This is the world’s most comprehensive hematology event of the year and it is very...
by Lawrence Mouawad | Nov 5, 2019 | Uncategorised
From June 13-16, 2019, the European Hematology Association holds the 24th EHA annual congress at RAI Amsterdam, The Netherlands. Address details RAI Amsterdam Europaplein 24, 1078 GZ Amsterdam, The Netherlands www.rai.nl/en More than 10.000 hematologists coming from...
by Lawrence Mouawad | Nov 5, 2019 | Uncategorised
More than 12,000 hematology professionals from around the world met together in Amsterdam, The Netherlands for the 24th European Hematology Association (EHA) Congress. This has been the largest EHA Congress ever recorded with a growth of more than a thousand attendees...
by Lawrence Mouawad | Oct 19, 2019 | Uncategorised
We’re proud to announce that Denis Costello has recently been appointed as the first Executive Director of the CML Advocates Network, the global umbrella organisation dedicated to empowering patient leaders in Chronic Myeloid Leukemia (CML). Denis comes to our CML...
by Lawrence Mouawad | Oct 2, 2019 | Uncategorised
When generic imatinib was introduced between 2013 and 2016 when the Glivec patent expired, generic formulations have been used recently as a more cost-effective treatment, but there are few studies that have prospectively evaluated the efficacy and safety of these...